Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Amag Says Shareholders Rejected Purchase of Allos

By Pharmaceutical Processing | October 21, 2011

Amag Pharmaceuticals Inc. will not acquire lymphoma drug maker Allos Therapeutics Inc., as Amag’s shareholders voted down the deal Friday.

 

Amag said its shareholders voted against issuing new stock. The company agreed to buy Allos in July for $268 million in stock, giving Allos shareholders 0.1282 shares of Amag for each Allos share they owned. Amag will pay Allos a $2 million breakup fee.

 

Investment firm and Amag shareholder MSMB Capital Management opposed the deal and moved to replace five of the six directors on Amag’s board.

 

Allos, of Westminster, Colo., said its shareholders voted in favor of the sale at a separate meeting on Friday.

 

Amag makes Feraheme, a drug that is used to treat iron deficiency anemia in adults who have chronic kidney disease. Allos sells the lymphoma treatment Folotyn.

 

Shares of Amag, which is based in Lexington, Mass., fell 8 cents to $13.56 in midday trading. Allos stock shed 2 cents to $1.44.

Related Articles Read More >

A Zipline fixed-wing drone in the air drops a package
Cardinal Health starts Zipline drone deliveries of drugs and medical supplies
Pfizer logo
Pfizer to spend $120M to make COVID-19 oral treatment in U.S.
Image of MedTrace Pharma's P3 automated delivery system for 15-O water in action
MedTrace Pharma moves forward on 15 O-water imaging tech
coronavirus COVID-19 Pfizer
NIH starts evaluating second COVID-19 booster shots in adults

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards